Federated Hermes’s Rentokil RTO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$4.85K Sell
154
-57
-27% -$1.8K ﹤0.01% 1894
2025
Q4
$6.22K Buy
211
+29
+16% +$806 ﹤0.01% 1877
2025
Q3
$4.6K Hold
182
﹤0.01% 1950
2025
Q2
$4.37K Hold
182
﹤0.01% 1898
2025
Q1
$4.17K Buy
182
+42
+30% +$1.01K ﹤0.01% 1896
2024
Q4
$3.54K Sell
140
-16
-10% -$405 ﹤0.01% 1927
2024
Q3
$3.89K Buy
156
+27
+21% +$800 ﹤0.01% 1881
2024
Q2
$3.83K Hold
129
﹤0.01% 1864
2024
Q1
$3.89K Buy
129
+18
+16% +$499 ﹤0.01% 1866
2023
Q4
$3.18K Buy
+111
New +$3.26K ﹤0.01% 1895

Other funds holding RTO

Federated Hermes's RTO Position: Q1 2026 in Review

Federated Hermes reduced its Rentokil (RTO) stake by 27% in Q1 2026, selling an estimated $1.8K and leaving 154 shares worth $4.85K. The position accounts for ﹤0.01% of the portfolio, ranked #1894.

Federated Hermes first reported a position in RTO in Q4 2023 and has held it in 10 quarters since. The position peaked at $6.22K in Q4 2025. 282 funds tracked by Wall St. Rank hold RTO as of Q1 2026.

  • Federated Hermes held 154 shares of Rentokil worth $4.85K as of Q1 2026.
  • Federated Hermes sold 57 Rentokil shares in Q1 2026, an estimated $1.8K.
  • Rentokil made up ﹤0.01% of Federated Hermes's portfolio in Q1 2026, its #1894 holding.
  • Federated Hermes first reported a position in Rentokil in Q4 2023 and has held it in 10 quarters since.
  • Federated Hermes's Rentokil position peaked at $6.22K in Q4 2025.
  • 282 funds tracked by Wall St. Rank held Rentokil as of Q1 2026.

Based on Federated Hermes's 13F filing for Q1 2026, filed 11 May 2026.